Search Results - "E. Yu. Ilushkina"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Lenalidomide for relapsed or refractory multiple myeloma by S. S. Bessmeltsev1, E. V. Kariagina, L. V. Stelmashenko, G. N. Salogub, E. R. Machulaitene, K. M. Abdulkadyrov, N. A. Kotova, I. I. Kostroma, N. V. Medvedeva, L. I. Krylova, E. Yu. Ilushkina

    Published in Onkogematologii͡a (01-07-2014)
    “…We report the activity of lenalidomide (revlimide – R), lenalidomide plus dexamethasone (Rd), lenalidomide plus bortezomib plus dexamethasone (RVd) in 34…”
    Get full text
    Journal Article
  2. 2

    Lenalidomide for relapsed or refractory multiple myeloma by S. S. Bessmeltsev1, E. V. Kariagina, L. V. Stelmashenko, G. N. Salogub, E. R. Machulaitene, K. M. Abdulkadyrov, N. A. Kotova, I. I. Kostroma, N. V. Medvedeva, L. I. Krylova, E. Yu. Ilushkina

    Published in Onkogematologii͡a (01-07-2014)
    “…We report the activity of lenalidomide (revlimide – R), lenalidomide plus dexamethasone (Rd), lenalidomide plus bortezomib plus dexamethasone (RVd) in 34…”
    Get full text
    Journal Article